Bioimpacts

Papers
(The H4-Index of Bioimpacts is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial83
A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: development of self-amplifying mRNA and peptide vaccines35
Cell cycle arrest and anti-cancer potential of probiotic Lactobacillus rhamnosus against HT-29 cancer cells31
Fluid-structure interaction of blood flow around a vein valve26
The active lung microbiota landscape of COVID-19 patients through the metatranscriptome data analysis22
Computational-based drug repurposing methods in COVID-1918
Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems16
Conditions for combining gene therapy with bone marrow transplantation in murine Krabbe disease16
Characterization of isolated compounds from Morus spp. and their biological activity as anticancer molecules14
Global metabolomics profiling of colorectal cancer in Malaysian patients14
Improved antibacterial activity of topical gel-based on nanosponge carrier of cinnamon oil14
In silico approach towards the identification of potential inhibitors from Curcuma amada Roxb against H. pylori: ADMET screening and molecular docking studies12
Designing a new generation of expression toolkits for engineering of green microalgae; robust production of human interleukin-212
0.088130950927734